(S)-ATPO | CAS#252930-37-3

MedKoo Cat#: 525387 | Name: (S)-ATPO

Description:

WARNING: This product is for research use only, not for human or veterinary use.

(S)-ATPO is a potent and Selective Ampa Receptor Antagonist.

Chemical Structure

(S)-ATPO

CAS#252930-37-3

Theoretical Analysis

MedKoo Cat#: 525387

Name: (S)-ATPO

CAS#: 252930-37-3

Chemical Formula: C11H19N2O7P

Exact Mass: 322.0930

Molecular Weight: 322.25

Elemental Analysis: C, 41.00; H, 5.94; N, 8.69; O, 34.75; P, 9.61

Price and Availability

Size	Price	Availability
100mg	USD 950.00	2 Weeks
200mg	USD 1,650.00	2 Weeks
500mg	USD 2,650.00	2 Weeks
1g	USD 3,450.00	2 Weeks
2g	USD 5,450.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

(S)-ATPO; (S)ATPO;

IUPAC/Chemical Name

(S)-2-amino-3-(5-(tert-butyl)-3-(phosphonomethoxy)isoxazol-4-yl)propanoic acid

InChi Key

AGSOOCUNMTYPSE-ZETCQYMHSA-N

InChi Code

InChI=1S/C11H19N2O7P/c1-11(2,3)8-6(4-7(12)10(14)15)9(13-20-8)19-5-21(16,17)18/h7H,4-5,12H2,1-3H3,(H,14,15)(H2,16,17,18)/t7-/m0/s1

SMILES Code

O=C(O)[C@@H](N)CC1=C(C(C)(C)C)ON=C1OCP(O)(O)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 322.25 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Hong A, Stokes B, Otahal P, Owens D, Burgess JR. Temporal trends for thyroid stimulating hormone (TSH) and thyroid peroxidase antibody (ATPO) testing across two phases of iodine fortification in tasmania (1995-2013). Clin Endocrinol (Oxf). 2017 May 13. doi: 10.1111/cen.13371. [Epub ahead of print] PubMed PMID: 28500624. 2: Dauksiene D, Petkeviciene J, Klumbiene J, Verkauskiene R, Vainikonyte-Kristapone J, Seibokaite A, Ceponis J, Sidlauskas V, Daugintyte-Petrusiene L, Norkus A, Zilaitiene B. Factors Associated with the Prevalence of Thyroid Nodules and Goiter in Middle-Aged Euthyroid Subjects. Int J Endocrinol. 2017;2017:8401518. doi: 10.1155/2017/8401518. Epub 2017 Mar 5. PubMed PMID: 28356911; PubMed Central PMCID: PMC5357546. 3: Mikos H, Mikos M, Niedziela M. Diagnostic significance of serum concentrations of soluble Fas ligand (sFasL) in children with autoimmune thyroid disease. Autoimmunity. 2017 May;50(3):192-198. doi: 10.1080/08916934.2017.1289180. Epub 2017 Feb 21. PubMed PMID: 28276714. 4: Wielosz E, Majdan M, Koszarny A, Dryglewska M, Tabarkiewicz J. Systemic sclerosis and organ - specific antibodies. Pol Arch Med Wewn. 2016 Oct 5. doi: 10.20452/pamw.3583. [Epub ahead of print] PubMed PMID: 27848930. 5: Møllerud S, Frydenvang K, Pickering DS, Kastrup JS. Lessons from crystal structures of kainate receptors. Neuropharmacology. 2017 Jan;112(Pt A):16-28. doi: 10.1016/j.neuropharm.2016.05.014. Epub 2016 May 26. Review. PubMed PMID: 27236079. 6: Anila KR, Nayak N, Jayasree K. Cytomorphologic spectrum of lymphocytic thyroiditis and correlation between cytological grading and biochemical parameters. J Cytol. 2016 Jul-Sep;33(3):145-149. PubMed PMID: 27756987; PubMed Central PMCID: PMC4995872. 7: Côté CL, Yip AM, MacLeod JB, O'Reilly B, Murray J, Ouzounian M, Brown CD, Forgie R, Pelletier MP, Hassan A. Efficacy of intraoperative cell salvage in decreasing perioperative blood transfusion rates in first-time cardiac surgery patients: a retrospective study. Can J Surg. 2016 Sep;59(5):330-6. PubMed PMID: 27668331; PubMed Central PMCID: PMC5042720. 8: Szepietowska B, Wawrusiewicz-Kurylonek N, Krętowski A, Górska M, Szelachowska M. Endocrine autoimmunity in patients with Latent Autoimmune Diabetes in Adults (LADA) — association with HLA genotype. Endokrynol Pol. 2016;67(2):197-201. doi: 10.5603/EP.a2016.0017. PubMed PMID: 26884287. 9: Piciu A, Andrianou XD, Irimie A, Bălăcescu O, Zira C, BĂRBUş E, Peştean C, Aristeidou K, Theofanous T, Agathokleous M, Piciu D, Makris KC. Investigation of thyroid nodules in the female population in Cyprus and in Romania. Clujul Med. 2015;88(4):494-9. doi: 10.15386/cjmed-518. Epub 2015 Nov 15. PubMed PMID: 26733748; PubMed Central PMCID: PMC4689243. 10: Jonak O, Połubok J, Barg E. Graves' disease in 2.5 years old girl - 6-years-long observation. Pediatr Endocrinol Diabetes Metab. 2016;22(2):76-79. doi: 10.18544/PEDM-22.02.0055. PubMed PMID: 28329777. 11: Giejda K, Piszczek S, Stembrowicz-Nowakowska Z, Saracyn M, Dziuk M, Kamiński G. Incidentally recognised thyroid focal uptake of 99mTc-sestamibi during stress myocardial perfusion scintigraphy. Endokrynol Pol. 2015;66(6):521-5. doi: 10.5603/EP.2015.0064. PubMed PMID: 26662651. 12: Drobniak A, Kanecki K, Grymowicz M, Radowicki S. Serum leptin concentration in women of reproductive age with euthyroid autoimmune thyroiditis. Gynecol Endocrinol. 2016;32(2):128-31. doi: 10.3109/09513590.2015.1092512. Epub 2015 Oct 6. PubMed PMID: 26440361. 13: Kamronn S, Poulsen AT, Hansen LK. Multiview Bayesian Correlated Component Analysis. Neural Comput. 2015 Oct;27(10):2207-30. doi: 10.1162/NECO_a_00774. Epub 2015 Aug 27. PubMed PMID: 26313603. 14: Manavela M, Vigovich C, Danilowicz K, Juri A, Miechi L, Fernandez Valoni V, Bruno OD. Thyroid autoimmune disorders in patients with acromegaly. Pituitary. 2015 Dec;18(6):912-5. doi: 10.1007/s11102-015-0670-5. PubMed PMID: 26163018. 15: Chaykivska Z, Antoszczyk G, Czarnobilska E. [The elevated level of anti-thyroid antibodies aTPO in chronic spontaneous urticaria]. Przegl Lek. 2015;72(12):736-8. Polish. PubMed PMID: 27024950. 16: Koukkou E, Kravaritis S, Mamali I, Markantes GG, Michalaki M, Adonakis GG, Georgopoulos NA, Markou KB. No increase in renal iodine excretion during pregnancy: a telling comparison between pregnant women and their spouses. Hormones (Athens). 2014 Jul-Sep;13(3):375-81. doi: 10.14310/horm.2002.1487. PubMed PMID: 25079462. 17: Jørgensen L, Nielsen B, Pickering DS, Kristensen AS, Frydenvang K, Madsen U, Clausen RP. Analogues of 3-hydroxyisoxazole-containing glutamate receptor ligands based on the 3-hydroxypyrazole-moiety: design, synthesis and pharmacological characterization. Neurochem Res. 2014 Oct;39(10):1895-905. doi: 10.1007/s11064-014-1332-0. Epub 2014 May 22. PubMed PMID: 24848194. 18: Rogowicz-Frontczak A, Zozuliłska-Ziołkiewicz D, Litwinowicz M, Niedźwiecki P, Wyka K, Wierusz-Wysocka B. Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes? Eur J Endocrinol. 2014 Mar 14;170(4):651-8. doi: 10.1530/EJE-13-0901. Print 2014 Apr. PubMed PMID: 24480135. 19: Koszarny A, Majdan M, Suszek D, Wielosz E, Dryglewska M. Relationship between rheumatoid arthritis activity and antithyroid antibodies. Pol Arch Med Wewn. 2013;123(7-8):394-400. Epub 2013 Jun 21. PubMed PMID: 23792346. 20: Marconcini ML, Fayad L, Shiozawa MB, Dantas-Correa EB, Lucca Schiavon Ld, Narciso-Schiavon JL. Autoantibody profile in individuals with chronic hepatitis C. Rev Soc Bras Med Trop. 2013 Mar-Apr;46(2):147-53. doi: 10.1590/0037-8682-0039-2013. PubMed PMID: 23740063.